- Report
- July 2023
- 147 Pages
Global
From €2138EUR$2,250USD£1,833GBP
- Report
- August 2023
- 190 Pages
Global
From €4559EUR$4,799USD£3,909GBP
- Report
- February 2024
- 250 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- September 2023
- 180 Pages
Global
From €5653EUR$5,950USD£4,847GBP
- Report
- May 2024
- 357 Pages
Global
From €5320EUR$5,600USD£4,562GBP
- Report
- May 2024
- 604 Pages
Global
From €5320EUR$5,600USD£4,562GBP
- Report
- November 2023
- 138 Pages
Global
From €2374EUR$2,499USD£2,036GBP
- Report
- February 2024
- 175 Pages
Global
From €3800EUR$4,000USD£3,259GBP
- Report
- December 2023
- 200 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- November 2023
- 175 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- May 2023
- 134 Pages
Global
From €2374EUR$2,499USD£2,036GBP
- Report
- November 2023
- 188 Pages
Global
From €4655EUR$4,900USD£3,992GBP
- Report
- October 2023
- 190 Pages
Global
From €4655EUR$4,900USD£3,992GBP
- Report
- August 2023
- 117 Pages
Global
From €4655EUR$4,900USD£3,992GBP
- Report
- November 2023
- 150 Pages
Global
From €3026EUR$3,185USD£2,595GBP
€4323EUR$4,550USD£3,707GBP
- Report
- February 2024
- 115 Pages
Global
From €4513EUR$4,750USD£3,870GBP
- Report
- January 2024
- 200 Pages
Global
From €3943EUR$4,150USD£3,381GBP
- Report
- September 2021
- 190 Pages
Global
From €4559EUR$4,799USD£3,909GBP
- Report
- December 2019
- 197 Pages
Global
From €4703EUR$4,950USD£4,032GBP
- Report
- March 2021
- 180 Pages
China
From €3230EUR$3,400USD£2,770GBP
Blood Plasma is a vital component of the pharmaceutical industry, used in the production of a variety of drugs and treatments. It is a component of the human body that is collected from healthy donors and used to create a range of products, including immunoglobulins, albumin, clotting factors, and other proteins. Plasma is also used to manufacture a variety of vaccines, including those for influenza, hepatitis, and rabies.
The demand for blood plasma has grown in recent years due to the increasing prevalence of chronic diseases and the need for more effective treatments. As a result, the market for blood plasma has become increasingly competitive, with a number of companies vying for a share of the market.
Some of the major players in the blood plasma market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. These companies are involved in the collection, processing, and distribution of blood plasma products, as well as the development of new treatments and therapies. Show Less Read more